CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-08-04. AI was used for research and drafting; the existence of all 2 cited sources was verified at the original page, followed by blind grading, adversarial audit, and build validation. Methodology v1.0.
Verdict No. 2141 · Search date 2026-08-04 · Methodology v1.0

Drinking coffee, 2 to 5 cups/day,
does it really help with Reduced all-cause mortality?

30-Second Summary
C
Evidence Grade C · 56 · Safety caution
Lower mortality appeared only after detailed smoking adjustment
Regular coffee can cause insomnia, anxiety, or palpitations, and intake may need adjustment for individual caffeine sensitivity and medications.
What the
research shows
The grade is C. At four to five cups/day, age-adjusted hazard ratios were 1.21 (95% CI 1.15 to 1.27) in men and 1.13 (1.07 to 1.20) in women; multivariable adjustment reversed the direction to 0.88 (0.84 to 0.93) and 0.84 (0.79 to 0.90). This was an observed association, not a randomized causal effect.
What the
ads claim
A lower adjusted hazard can be reported, but it is not proof that assigning coffee extends life. The decisive limitation is that smoking adjustment reversed the apparent direction.
*

Useful facts when choosing a product

  • Brewing method, cup volume, and study-specific caffeine content were not reported.
  • FDA general data place caffeine at 113 to 247 mg per 355 mL regular brewed coffee and 2 to 15 mg per 237 mL decaf; these were not measurements of study beverages.
  • Paper filtration can alter coffee lipids, but filtration was not separated in this cohort.
ID

Chamgap Semantic Classification Code

Candidate index · review held

F.drinking-coffee.food.all-cause-mortality.reduce.UNK

Foods and beverages > Drinking coffee > Food consumption > all-cause mortality > Reduction claim > Unknown

An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.

Download semantic index (JSON) · Codebook v1

Gap Measurement · Verdict 2141 · C 56
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The NIH-AARP cohort followed 402,260 adults, 229,119 men and 173,141 women, for a median 13.6 years and recorded 52,515 deaths. The reference was current nonconsumption at baseline; lifelong abstainers were not analyzed separately. Results were similar after excluding the first four or first nine years. Caffeinated and decaffeinated coffee pointed in the same direction. Models included detailed smoking intensity and cessation, health, diet, and activity. The work came from the US National Cancer Institute research network.

02

Why this is classified as C (56)

A large hard-outcome association remains observational and is limited by direction-changing smoking adjustment, a contaminated reference group, baseline self-report, and multiple modeling choices, giving C with 56 points.

Counterpoint. C does not mean coffee is harmful; it means the association is not yet a demonstrated causal life-extension effect.

Rejudgment record. Cross-check applied — A large hard-outcome association remained, but direction-changing smoking adjustment and contamination of the current-nondrinker reference group limit causal inference

Stored scoring profile
EndpointHHard endpoint - actual events such as death
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE+Meets the clinically important threshold

Stored derived and displayed grades match; this is not a current recalculation or validity check (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Association of 4 to 5 cups/day with lower all-cause mortality hazardCAdjusted intervals excluded 1 in both sexes, but evidence was observational.

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Freedman et al. 2012 NIH-AARPLarge prospective cohort402,260 analyzed, 52,515 deaths, median follow-up 13.6 yearsUS National Cancer Institute research networkAll-cause mortality from 1995 to 2008Four to five cups/day versus none: HR 0.88 (0.84-0.93) in men and 0.84 (0.79-0.90) in womenCore observational evidence; direction reversed after smoking adjustment
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-04).

Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of Coffee Drinking with Total and Cause-Specific Mortality. N Engl J Med. 2012;366:1891-1904. PMID: 22591295. DOI: 10.1056/NEJMoa1112010.
checked
U.S. Food and Drug Administration. Spilling the Beans: How Much Caffeine is Too Much?
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Evidence date: 2026-08-04 · Corrections: none

Cite this verdict

Drinking coffee, 2 to 5 cups/day x reduced all-cause mortality Evidence Grade C card
[Chamgap] Drinking coffee, 2 to 5 cups/day x reduced all-cause mortality — Evidence Grade C·56. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/antioxidant-aging/coffee-two-to-five-cups-all-cause-mortality/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.